C Fribbens, B O'Leary, L Kilburn, S Hrebien… - Journal of clinical …, 2016 - ascopubs.org
Purpose ESR1 mutations are selected by prior aromatase inhibitor (AI) therapy in advanced
breast cancer. We assessed the impact of ESR1 mutations on sensitivity to standard …